AYTU BIOPHARMA, INC Increase (Decrease) in Prepaid Rent
AYTU BIOPHARMA, INC (AYTU) reported Increase (Decrease) in Prepaid Rent of $5.00 thousand for the 9-month period ending 2018-03-31, per its 10-Q filed 2018-05-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidRent · last filed 2018-05-14
- AYTU BIOPHARMA, INC increase (decrease) in prepaid rent for the quarter ending 2018-03-31 was $1.67K, a 17.05% increase year-over-year.
- AYTU BIOPHARMA, INC increase (decrease) in prepaid rent for the quarter ending 2017-12-31 was $1.67K, a 17.05% increase year-over-year.
- AYTU BIOPHARMA, INC increase (decrease) in prepaid rent for the quarter ending 2017-09-30 was $1.67K.
- AYTU BIOPHARMA, INC increase (decrease) in prepaid rent for the quarter ending 2017-06-30 was $1.43K.
- AYTU BIOPHARMA, INC increase (decrease) in prepaid rent for fiscal 2017 was $4.20K.
- AYTU BIOPHARMA, INC increase (decrease) in prepaid rent for fiscal 2016 was -$10.88K.
- AYTU BIOPHARMA, INC increase (decrease) in prepaid rent for fiscal 2015 was $0.00.
| Period end | Increase (Decrease) in Prepaid Rent 3 month | Increase (Decrease) in Prepaid Rent 6 month | Increase (Decrease) in Prepaid Rent 9 month | Increase (Decrease) in Prepaid Rent 12 month |
|---|---|---|---|---|
| 2018-03-31 | $1.67K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-14 | $3.34K derived: sum of 2 quarters · filed 2018-05-14 | $5.00K 10-Q · filed 2018-05-14 | $6.43K derived: sum of 4 quarters · filed 2018-05-14 |
| 2017-12-31 | $1.67K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-08 | $3.34K 10-Q · filed 2018-02-08 | $4.76K derived: sum of 3 quarters · filed 2018-02-08 | $6.19K derived: sum of 4 quarters · filed 2018-05-14 |
| 2017-09-30 | $1.67K 10-Q · filed 2017-11-09 | $3.09K derived: sum of 2 quarters · filed 2017-11-09 | $4.52K derived: sum of 3 quarters · filed 2018-05-14 | $5.94K derived: sum of 4 quarters · filed 2018-05-14 |
| 2017-06-30 | $1.43K derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-31 | $2.85K derived: sum of 2 quarters · filed 2018-05-14 | $4.28K derived: sum of 3 quarters · filed 2018-05-14 | $4.20K 10-K · filed 2017-08-31 |
| 2017-03-31 | $1.43K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-14 | $2.85K derived: sum of 2 quarters · filed 2018-05-14 | $2.77K 10-Q · filed 2018-05-14 | $2.46K derived: sum of 4 quarters · filed 2018-05-14 |
| 2016-12-31 | $1.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-08 | $1.35K 10-Q · filed 2018-02-08 | $1.03K derived: sum of 3 quarters · filed 2018-02-08 | $720.00 derived: sum of 4 quarters · filed 2018-02-08 |
| 2016-09-30 | -$75.00 10-Q · filed 2017-11-09 | -$390.00 derived: sum of 2 quarters · filed 2017-11-09 | -$705.00 derived: sum of 3 quarters · filed 2017-11-09 | $429.00 derived: sum of 4 quarters · filed 2017-11-09 |
| 2016-06-30 | -$315.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-31 | -$630.00 derived: sum of 2 quarters · filed 2017-08-31 | $504.00 derived: sum of 3 quarters · filed 2017-08-31 | -$10.88K 10-K · filed 2017-08-31 |
| 2016-03-31 | -$315.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-11 | $819.00 derived: sum of 2 quarters · filed 2017-05-11 | -$10.56K 10-Q · filed 2017-05-11 | -$10.56K derived: sum of 4 quarters · filed 2017-05-11 |
| 2015-12-31 | $1.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-09 | -$10.24K 10-Q · filed 2017-02-09 | -$10.24K derived: sum of 3 quarters · filed 2017-02-09 | -$10.24K derived: sum of 4 quarters · filed 2017-02-09 |
| 2015-09-30 | -$11.38K 10-Q · filed 2016-11-07 | -$11.38K derived: sum of 2 quarters · filed 2016-11-07 | -$11.38K derived: sum of 3 quarters · filed 2016-11-07 | |
| 2015-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-01 | $0.00 derived: sum of 2 quarters · filed 2016-09-01 | $0.00 10-K · filed 2016-09-01 | |
| 2015-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-11 | $0.00 10-Q · filed 2016-05-11 | ||
| 2014-12-31 | $0.00 10-Q · filed 2016-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |